1.
Bioorg Med Chem Lett
; 13(16): 2625-8, 2003 Aug 18.
Article
in English
| MEDLINE
| ID: mdl-12873480
ABSTRACT
A Hit-to-Lead optimisation programme was carried out on the high throughput screening hit, the triazolethiol 1, resulting in the discovery of the potent, orally bioavailable triazolethiol CXCR2 receptor antagonist 45.